Browse & search snapshots

Links related to Canada's Access to Medicines Regime Listed below are hyperlinks to websites that contain further information about Canada's Access to Medicines Regime . Access to these websites requires that the user's computer has an active Internet connection. Government of…

Canada's investments in global health: Canada's Access to Medicines Regime Canada, through the Canadian International Development Agency (CIDA), is a leading donor to health funding in the developing world. Canada's commitments include support to global health partnerships and…

Forms: Canada's Access to Medicines Regime Documents The most up-to-date forms to obtain authorization in Canada are available on the Canadian Intellectual Property Office (CIPO) Web site. The required CIPO forms include: Application for Authorization Under Section 21.04 of the…

Patent Act Schedules related to Canada's Access to Medicines Regime Schedule 1 - Pharmaceutical Products Eligible for Export Schedule 2 - Least-Developed Countries Eligible to Import Under the Regime Schedule 3 - WTO-Member Countries Eligible to Import Under the Regime Schedule 4…

Report on the Statutory Review of Sections 21.01 to 21.19 of the Patent Act - Canada's Access to Medicines Regime Help on accessing alternative formats, such as Portable Document Format ( PDF ), Microsoft Word and PowerPoint ( PPT ) files, can be obtained in the alternate format…

Contact information related to Canada's Access to Medicines Regime Canadian Federal Government Contacts Director Patent Policy Directorate Industry Canada 235 Queen Street Ottawa, Ontario K1A 0H5 Telephone: (613) 952-2118 Director Bureau of Policy, Science and International…

Submissions received in response to Canada's Access to Medicines Regime 2006 consultation Industry Canada and Health Canada respects the Official Languages Act and the relevant Treasury Board policies, and is committed to ensuring all information and services on this site are…

Benefits for companies participating in Canada's Access to Medicines Regime The pharmaceutical company must complete and submit to the Commissioner of Patents a Solemn or Statutory Declaration Under Paragraph 21.04(3)( c ) of the Patent Act . The form sets out the information…

Country access to Canada's Access to Medicines Regime Countries with insufficient or no manufacturing capacity in the pharmaceutical sector can benefit from participating in Canada's Access to Medicines Regime . Under the Regime, eligible countries can import less expensive,…

Introduction to the Canada's Access to Medicines Regime The Government of Canada is committed to improving access to drugs and medical devices that are needed to address public health problems afflicting many developing and least-developed countries, especially those resulting…